Nuclear. For Health.
Medical isotopes: our mission for a healthier world
At NRG PALLAS, we are driven by a single purpose: enabling life-saving diagnostics and therapies through nuclear medical products. Medical isotopes are our top priority. That’s why we invest in long-term, strategic partnerships with leading global players – and are building the most reliable and future-proof infrastructure in the sector.
Our unique facilities cover the entire nuclear medicine value chain – from the production of radioisotopes in our nuclear reactor, to their processing into radionuclide precursors in our GMP-certified laboratories. We offer production, recycling, and waste management – all under one roof, sustainably and efficiently.
Medical Isotopes & The Netherlands Cancer Institute
At the Netherlands Cancer Institute in Amsterdam, medical isotopes supplied by NRG PALLAS are also used, including for the treatment of prostate cancer with Lutetium-177. Curious to see inside the Netherlands Cancer Institute? Watch the video where we visit the institute and hear from the experts.
Our licences and regulatory expertise allow our clients to focus on what they do best: developing innovative therapies. Thanks to our specialised transport team, certified containers, and cross-border logistics, we ensure safe, rapid delivery in line with the highest standards.
At the heart of our forward-looking approach is the PALLAS reactor – the only reactor under construction specifically optimised for the production of medical isotopes. As existing reactor capacity in Europe declines, we are building continuity – and a healthier future for millions of patients worldwide.
NRG PALLAS: your trusted partner in nuclear medicine. Today and tomorrow.
"30.000 per dag"
Every day, medical isotopes produced in the reactor in Petten are of critical importance to more than 30,000 people worldwide. These isotopes form the foundation of nuclear medicines and are essential for diagnosing and treating conditions such as cardiovascular diseases and cancer.
